Summary & Overview
CPT 16033: Lesion Excision Procedure
CPT code 16033 denotes a specific surgical procedure for excision of a lesion. This code is part of the Current Procedural Terminology (CPT) system and is used in billing for surgical services. Accurate use of this code affects clinical documentation, claims adjudication, and national reimbursement reporting, making it important for providers, billing professionals, and payers.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a national-level overview of clinical context associated with the code, common billing considerations, and the types of benchmarks and policy updates that impact its use. The publication outlines typical billing patterns, payer coverage considerations, and related coding guidance where available.
This summary equips coding professionals and healthcare administrators with a concise reference to understand where CPT code 16033 fits in surgical service lines, what stakeholders commonly monitor, and which topics to review for coding accuracy and compliance.
Billing Code Overview
CPT code 16033 represents the surgical excision of a lesion. The description provided is 16033.
Service type: Data not available in the input.
Typical site of service: Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or adolescent presenting to a dermatology clinic or ambulatory surgical center with one or more benign epidermal or dermal lesions (such as common warts, molluscum contagiosum, small verrucae, or small benign hyperkeratotic lesions) requiring removal by chemical cauterization. The clinician evaluates the lesion(s), documents size, location, and number of lesions, and discusses procedure risks and expected healing. After obtaining verbal or written consent, the provider prepares the area with antiseptic, isolates the lesion, and applies a chemical cauterant (for example, trichloroacetic acid or silver nitrate) to each lesion until the intended tissue destruction is achieved. Post-procedure instructions and wound care are provided, and the procedure, number of lesions treated, and type of chemical agent are documented in the medical record. Typical sites of service include dermatology outpatient clinics, primary care offices, urgent care centers, and ambulatory procedure suites.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when a distinct E/M visit is performed and documented on the same day as the chemical cauterization |
59 |